Stress Reduction Program to Reduce Abnormal Heart Rhythms Treated With Implantable Cardioverter Defibrillators (The RISTA Study)

Conditions

Arrhythmias, Cardiac

What is the purpose of this trial?

An implantable cardioverter defibrillator (ICD) is a small device that is implanted in the chest and uses electrical shocks to control arrhythmias, which are abnormal heart rhythms. Arrhythmias can be caused by many factors, including stress and anger. This study will evaluate the use of a stress reduction treatment (SRT) program aimed at reducing the occurrence of arrhythmias that require treatment with an ICD shock.



Participation Guidelines

Age:
21 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Yale University
Dates:
January 2008
Last Updated:
March 30, 2012
Study HIC#:
09907011081

Clinicaltrials.gov ID: NCT00627263